A key lung cancer congress held in Europe disclosed that a new breakthrough has been made by Hengrui Pharmaceuticals, a ...

Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal cancer scans, potentially offering drugmakers a better way to design their ...

targeting individuals with locally advanced or metastatic non-small cell lung cancer. "China conditionally approves Hutchmed’s Tazverik for follicular lymphoma" was originally created and ...

and China (39 years). According to a paper in Asian Pacific Journal of Cancer Care, there is a history of active tobacco smoking in 87% of males and in 85% of females. History of passive smoking is ...

SAVANNAH: Savolitinib (savo) + osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and MET overexpression (OverExp) and/or amplification (Amp) following progressive disease (PD) on osi ...

Lung cancer is broadly split into SCLC or NSCLC ... Savolitinib is approved in China and is marketed under the brand name ORPATHYS® by our partner, AstraZeneca, for the treatment of adult ...

Credit: create jobs 51 / Shutterstock. Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, which aims to aid in lung cancer ...

However, the current evidence of Chinese herbal medicine (CHM ... Experimental studies on the frequent botanical drugs have found anti-cancer effects that may explain their mechanisms. However, due to ...

Smoking isn’t the only lifestyle choice that might be damaging your lungs. Scientists have uncovered a surprising new villain in the fight against lung cancer: the combination of sugar and fat in your ...